Welcure Drugs and Pharmaceuticals Ltd.BSE: WELCURE

Board Meeting Intimation for Intimation Of Meeting Of The Board Of Directors Under The Regulation 29 Of TheSecurities And Exchange Board Of India (Listing Obligations And Disclosure Requirements),Regulations, 2015.

· Issued by Welcure Drugs and Pharmaceuticals Ltd. via BSE India

Filed with BSE ·

Welcure Drugs & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/05/2025 ,inter alia, to consider and approve To consider the appointment of Mr. Chintan Didawala Ganpat (DIN: 11088268) as ManagingDirector of the Company.2. To consider the Alteration in Main Objects Clause of Memorandum of Association of the Company by addition of New Objects.3. To consider the Increase in the Authorized Share Capital of the Company and consequent amendment in Memorandum of the Company, if any;4. Conduct Postal Ballot by means of E-voting for obtaining approval of the members of the Company

View Attachment

6ix hasn’t read this filing yet.

View original source (BSE India)Welcure Drugs and Pharmaceuticals Ltd. on 6ix

Story so far

Earlier from Welcure Drugs and Pharmaceuticals

Later from Welcure Drugs and Pharmaceuticals

All Welcure Drugs and Pharmaceuticals news releases